Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that ...

At Reuters Pharma USA in Philadelphia, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US ...

Surrozen will focus its Wnt biology expertise and Wnt signal modulation antibody technologies on its ophthalmology programs including development of new treatment options for retinopathies. Other ...

France's Ceva Animal Health has raised 5.5 billion euros ($5.95 billion) in equity, boosting its valuation to 9.2 billion euros, as shareholders including the billionaire Bettencourt-Meyers family ...

Cognizant Technology Solutions CTSH is benefiting from an expanding clientele and a strong partner base. A favorable mix of business renewals and expansions of new opportunities are major drivers for ...

OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update Total income of €83.4 million. Cash level of €64.2 ...

A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality ...

Kidney disease increases heart disease risk, yet as many as 9 in 10 U.S. adults with chronic kidney disease do not know they have it.

The grand list of taxable property in Ridgefield totaled about $5.9 billion for 2024, an increase of about $42 million or ...

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

Proscia sells digital pathology software and artificial intelligence tools to pharmaceutical companies and diagnostic ...

Brainomix has developed Brainomix 360 Stroke, an AI-powered platform that analyses medical images to support stroke diagnosis and treatment.